1 min read

Ubiquitin, protein degradation, and cancer drugs

Hershko, Ciechanover, and Rose discovered how cells tag selected proteins with ubiquitin and route them to the proteasome for breakdown. Later work on this system helped establish proteasome inhibitors as cancer treatments.

Miriam Bernstein

Miriam Bernstein is the pen name of Hasbara’s Resources desk. Articles on this desk are written and published automatically by artificial intelligence, with no person reviewing them before publication.

Avram Hershko, Aaron Ciechanover, and Irwin Rose discovered how cells mark selected proteins with ubiquitin and direct them to the proteasome for breakdown. Their 2004 Nobel Prize recognized this basic mechanism of cellular regulation; later research on the proteasome produced treatments such as bortezomib.

How the ubiquitin tag directs breakdown

Ubiquitin is a small protein made of 76 amino acids. Enzymes attach ubiquitin molecules to a target protein; this tag signals the proteasome, a large protein complex that degrades the target. The system lets cells regulate the amount and timing of proteins involved in processes such as the cell cycle and DNA repair. The Nobel citation names the discovery as ubiquitin-mediated protein degradation.

Hershko and Ciechanover carried out key research at the Technion in Haifa, working with Rose, who was at Fox Chase Cancer Center in Philadelphia. The Nobel record documents the prize and the researchers’ institutions. Ciechanover’s Nobel profile describes this research history.

From cell biology to treatment

The discovery gave later researchers a defined pathway to investigate. Bortezomib inhibits proteasome activity and is approved to treat multiple myeloma and mantle cell lymphoma in specified patients. This is a later therapeutic application of proteasome research, not the treatment discovered by the Nobel laureates. The National Cancer Institute’s drug record lists its approved cancer uses.

For the full prize roster, see Israeli and Israel-linked Nobel laureates in science.

Sources

  1. 1.https://www.nobelprize.org/prizes/chemistry/2004/summary/
  2. 2.https://www.nobelprize.org/prizes/chemistry/2004/ciechanover/facts/
  3. 3.https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib

Accessibility

These settings are saved on this device.

Preview

Read clearly, your way

Adjust this page while you read. Explore resources

Text
Text sizeApplies across the site.
Colour and contrast
Theme
Motion
AnimationsMatch device follows your reduced motion setting.